(NASDAQ: IVVD) Invivyd's forecast annual revenue growth rate of 49.53% is forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 32.77%, and it is also forecast to beat the US market's average forecast revenue growth rate of 13.34%.
Invivyd's revenue in 2026 is $58,365,000.On average, 5 Wall Street analysts forecast IVVD's revenue for 2026 to be $19,031,393,194, with the lowest IVVD revenue forecast at $15,223,110,196, and the highest IVVD revenue forecast at $22,469,459,208. On average, 5 Wall Street analysts forecast IVVD's revenue for 2027 to be $26,928,569,517, with the lowest IVVD revenue forecast at $15,309,769,267, and the highest IVVD revenue forecast at $35,500,743,368.
In 2028, IVVD is forecast to generate $62,055,558,795 in revenue, with the lowest revenue forecast at $37,667,220,151 and the highest revenue forecast at $96,501,065,853.